RVVTF Stock Price, Chart, Stats & News

Revive Therapeutics Ltd., a life sciences firm founded in 2012 and headquartered in Toronto, Canada, is focused on discovering and advancing treatments for uncommon diseases and infectious illnesses. The company maintains a pharmaceutical pipeline centered on cannabinoids, specifically targeting rare inflammatory conditions. Key developments in its therapeutic portfolio include: Bucillamine: Currently in Phase 3 clinical trials, it is being investigated for combating infectious diseases such as influenza and COVID-19.